Mave Health Secures $2.1 Million in Seed Funding
Mave Health, a neurotechnology startup, has successfully raised $2.1 million in a seed funding round led by Blume Ventures. The round also saw participation from Stanford Angels, Dhaval Shroff, and Raymond Russell. The company, based in both San Francisco, California, USA, and Bengaluru, Karnataka, India, focuses on developing a wearable headset designed to improve focus, sleep, and mood through gentle, targeted stimulation that supports prefrontal cortex activity.
Company Founders and Executives
Mave Health was founded in 2023 by Dhawal Jain, who serves as the CEO, alongside Co-Founders Aman Kumar, the Chief Technology Officer, and Jai Sharma. The founders have emphasized the importance of strengthening the brain's underlying systems for better focus and mood regulation. "The brain is the most complex system we rely on every day, and modern life is constantly overloading it," said Dhawal Jain. "Instead of chasing short-term boosts that come with long-term costs, we believe in strengthening the underlying systems that drive focus, mood, and stress regulation."
Product Overview
The company’s flagship product is a non-invasive wearable headset that uses transcranial direct current stimulation (tDCS) technology. This device delivers low-intensity electrical stimulation to the prefrontal cortex, a brain region associated with attention and emotional control. Designed for everyday use, the headset weighs about 100 grams and operates at an intensity of 1-2 mA. It can be used for 20 minutes a day during activities such as working, reading, or meditating, and lasts up to a month on a single charge with regular use. A companion mobile app allows users to log their sessions, personalize usage, and track progress.
Strategic Use of Funds
The newly acquired funds will be instrumental in expanding the launch of Mave Health's wearable headset in both the United States and India. This expansion aims to bring their innovative technology to a broader audience, addressing the growing demand for effective mental performance tools.
Conclusion
Mave Health's recent funding round highlights the growing interest in neurotechnology solutions designed to enhance mental well-being. With its innovative approach and strong support from investors, the company is well-positioned to make significant strides in the mental health and wellness industry.